This inventor holds 1 USPTO granted patent. Top assignees: British Columbia Cancer Agency Branch, Fundacio Clinic, Hospital Clinic De Barcelona. Active years: 2020.
Company Filing History:
1 out of 66 
1 out of 2 
1 out of 26 
Years Active: 2020
Title: **Emilio Montserrat: Innovator in Lymphoma Diagnosis**
Introduction
Emilio Montserrat, based in Barcelona, Spain, is a notable inventor with a significant contribution to the field of medical diagnostics. With a keen focus on enhancing the identification and understanding of lymphomas, he has developed a patented invention that leverages gene expression data for better diagnostic accuracy and survival predictions.
Latest Patents
Montserrat holds a patent titled "Methods for identifying, diagnosing, and predicting survival of lymphomas." This innovative patent outlines methods that utilize gene expression patterns to accurately identify lymphoproliferative disorders and predict patient survival. His invention includes the Lymph Dx microarray, which is designed to gather essential gene expression data from lymphoma samples. By utilizing this information, healthcare providers can more effectively determine the identity of specific lymphomas and tailor therapeutic approaches to improve patient outcomes.
Career Highlights
Throughout his career, Emilio Montserrat has collaborated with prominent institutions such as the University of Nebraska and the United States Department of Health and Human Services. His work has positioned him as a key figure in lymphoma research, contributing valuable insights that bridge the gap between genetic research and practical medical applications.
Collaborations
Some of the notable colleagues that Montserrat has worked with include distinguished scientists Louis M. Staudt and George Wright. Their collaborative efforts have undoubtedly enriched the research landscape surrounding lymphomas and helped advance the understanding of these complex disorders.
Conclusion
Emilio Montserrat has made a lasting impact in the field of lymphoma diagnosis through his innovative inventions and collaborative spirit. His dedication to improving patient care through genetic research serves as an inspiration for current and future inventors in the medical field. With his contributions, the potential for enhanced diagnostic methods and tailored treatments in oncology continues to grow.